ROKIT Healthcare Inc. (KOSDAQ:376900)
South Korea
· Delayed Price · Currency is KRW
82,200
-6,000 (-6.80%)
At close: Apr 28, 2026
ROKIT Healthcare Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,293,724 | 1,022,880 | - | - | - | - | |
| Enterprise Value | 1,287,792 | 1,012,544 | - | - | - | - | |
| Last Close Price | 82200.00 | 65500.00 | - | - | - | - | |
| Forward PE | 150.55 | 132.39 | - | - | - | - | |
| PS Ratio | 49.29 | 38.97 | - | - | - | - | |
| PB Ratio | 111.97 | 88.53 | - | - | - | - | |
| P/TBV Ratio | 123.07 | 97.31 | - | - | - | - | |
| EV/Sales Ratio | 49.06 | 38.58 | - | - | - | - | |
| EV/EBITDA Ratio | - | 1211.74 | - | - | - | - | |
| EV/EBIT Ratio | - | 28460.02 | - | - | - | - | |
| Debt / Equity Ratio | 2.26 | 2.26 | -0.34 | -0.22 | -0.12 | -0.10 | |
| Debt / EBITDA Ratio | 31.30 | 31.30 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.51 | -0.51 | -0.24 | -0.18 | -0.06 | -0.05 | |
| Net Debt / EBITDA Ratio | -7.09 | -7.09 | -2.00 | -1.42 | -0.34 | -0.26 | |
| Net Debt / FCF Ratio | 0.34 | 0.34 | -2.02 | -2.20 | -0.63 | -0.34 | |
| Asset Turnover | 0.79 | 0.79 | 1.32 | 1.10 | 0.63 | 0.37 | |
| Inventory Turnover | 5.58 | 5.58 | 4.87 | 4.12 | 1.82 | 1.69 | |
| Quick Ratio | 1.16 | 1.16 | 0.15 | 0.07 | 0.07 | 0.07 | |
| Current Ratio | 1.29 | 1.29 | 0.19 | 0.11 | 0.13 | 0.12 | |
| Return on Assets (ROA) | 0.07% | 0.07% | -38.13% | -41.75% | -59.29% | -59.35% | |
| Return on Capital Employed (ROCE) | 0.20% | 0.20% | 15.10% | 15.60% | 19.60% | 22.30% | |
| Earnings Yield | -0.22% | -0.28% | - | - | - | - | |
| FCF Yield | -1.34% | -1.70% | - | - | - | - | |
| Buyback Yield / Dilution | -64.22% | -64.22% | 34.20% | -0.64% | -72.42% | -6.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.